tirzepatide and general anesthesia Perioperative management of patients taking glucagon-like peptide 1 receptor agonists: Society for Perioperative Assessment Quality Improvement (SPAQI) multidisciplinary consensus statement ASA: Hold GLP-1 Agonists Before

Clinical studies comparing semaglutide vs tirzepatide have reported gastrointestinal adverse events such as nausea, gastroenteritis, and, rarely, pancreatitis

This article is educational and uses a 6 mg/mL example

The NIDDK lists tirzepatide among FDA-approved long-term medications for adults with obesity or overweight when appropriate

GLP-1-based agents The development of GLP-1 receptor agonists (GLP-1RAs) is centered around the creation of GLP-1 derivatives with modified properties that make them resistant to the action of the DPP-4 enzyme and have slow renal clearance

It is also effective for blood circulation

[DOI] [Google Scholar] 225.Gupta S., Chaturvedi P., Kulkarni M.G., Van Staden J